Literature DB >> 25766147

Newer oral anticoagulants.

A N Robinson, C Scully.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25766147     DOI： 10.1038/sj.bdj.2015.151

Source DB:  PubMed          Journal:  Br Dent J        ISSN： 0007-0610            Impact factor:   1.626


× No keyword cloud information.
  4 in total

1.  Dabigatran: how the drug company withheld important analyses.

Authors:  Deborah Cohen
Journal:  BMJ       Date:  2014-07-23

2.  Measurement of non-coumarin anticoagulants and their effects on tests of Haemostasis: Guidance from the British Committee for Standards in Haematology.

Authors:  Steve Kitchen; Elaine Gray; Ian Mackie; Trevor Baglin; Mike Makris
Journal:  Br J Haematol       Date:  2014-06-14       Impact factor: 6.998

Review 3.  Dabigatran (Pradaxa(®)): surgeon's friend or foe?

Authors:  N Syyed; M Ansell; V Sood
Journal:  Br Dent J       Date:  2014-12-05       Impact factor: 1.626

4.  Use of PER977 to reverse the anticoagulant effect of edoxaban.

Authors:  Jack E Ansell; Sasha H Bakhru; Bryan E Laulicht; Solomon S Steiner; Michael Grosso; Karen Brown; Victor Dishy; Robert J Noveck; James C Costin
Journal:  N Engl J Med       Date:  2014-11-05       Impact factor: 91.245
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.